Gemtuzumab: time to bring back on the market?

Clinical advances in hematology & oncology : H&O

Volumn 10, Issue 5, 2012, Pages 326-327

  Foran, James M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTINEOPLASTIC AGENT; GEMTUZUMAB; MONOCLONAL ANTIBODY;

CLINICAL TRIAL (TOPIC); DRUG RECALL; HUMAN; LEUKEMIA, MYELOID, ACUTE; RESEARCH; TREATMENT OUTCOME;

AMINOGLYCOSIDES; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; RESEARCH; SAFETY-BASED DRUG WITHDRAWALS; TREATMENT OUTCOME;

EID: 84894508098     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)